Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Brunner

Showing results (81-90 of 100) with videos related to

Pageof 10
Sort By:
Physical Review Letters|October 13, 2007
Control of magnetic anisotropy in (Ga,Mn)as by lithography-induced strain relaxationJ Wenisch, C Gould, L Ebel, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1982
Pharmacokinetic approach to the selection of dose schedules for medroxyprogesterone acetate in clinical oncologyV Tamassia, A Battaglia, F Ganzina, et al.
Cancer Treatment Reports|March 1, 1982
Multiple myeloma resistant to melphalan: treatment with doxorubicin, cyclophosphamide, carmustine (BCNU), and prednisoneR A Kyle, T F Pajak, E S Henderson, et al.
Cancer|January 1, 1981
The superiority of CCNU in the treatment of advanced Hodgkin's disease: Cancer and Leukemia Group B StudyH H Hansen, O S Selawry, T F Pajak, et al.
Physical Review Letters|June 13, 2009
Nonthermal photocoercivity effect in a low-doped (Ga,Mn)As ferromagnetic semiconductorG V Astakhov, H Hoffmann, V L Korenev, et al.
Physical Review Letters|February 26, 2021
Femtosecond Transfer and Manipulation of Persistent Hot-Trion Coherence in a Single CdSe/ZnSe Quantum DotP Henzler, C Traum, M Holtkemper, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 1998
Augmented therapy of extensive Hodgkin's disease: radiation to known disease or prolongation of induction chemotherapy did not improve survival--results of a Cancer and Leukemia Group B studyM Coleman, S Rafla, K J Propert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1988
Vincristine and prednisone prolong the survival of patients receiving intravenous or oral melphalan for multiple myeloma: Cancer and Leukemia Group B experienceG G Cornwell, T F Pajak, S Kochwa, et al.
Cancer Clinical Trials|January 1, 1981
MER immunotherapy and combination chemotherapy for advanced, recurrent Hodgkin's disease. Cancer and Leukemia Group B studyV Vinciguerra, M Coleman, T F Pajak, et al.
The Review of Scientific Instruments|January 3, 2020
Multicolor femtosecond pump-probe system with single-electron sensitivity at low temperatures and high magnetic fieldsC Traum, P Henzler, S Lohner, et al.
Pageof 10

Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
Physical Review Letters|October 13, 2007
Control of magnetic anisotropy in (Ga,Mn)as by lithography-induced strain relaxationJ Wenisch, C Gould, L Ebel, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1982
Pharmacokinetic approach to the selection of dose schedules for medroxyprogesterone acetate in clinical oncologyV Tamassia, A Battaglia, F Ganzina, et al.
Cancer Treatment Reports|March 1, 1982
Multiple myeloma resistant to melphalan: treatment with doxorubicin, cyclophosphamide, carmustine (BCNU), and prednisoneR A Kyle, T F Pajak, E S Henderson, et al.
Cancer|January 1, 1981
The superiority of CCNU in the treatment of advanced Hodgkin's disease: Cancer and Leukemia Group B StudyH H Hansen, O S Selawry, T F Pajak, et al.
Physical Review Letters|June 13, 2009
Nonthermal photocoercivity effect in a low-doped (Ga,Mn)As ferromagnetic semiconductorG V Astakhov, H Hoffmann, V L Korenev, et al.
Physical Review Letters|February 26, 2021
Femtosecond Transfer and Manipulation of Persistent Hot-Trion Coherence in a Single CdSe/ZnSe Quantum DotP Henzler, C Traum, M Holtkemper, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 1998
Augmented therapy of extensive Hodgkin's disease: radiation to known disease or prolongation of induction chemotherapy did not improve survival--results of a Cancer and Leukemia Group B studyM Coleman, S Rafla, K J Propert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1988
Vincristine and prednisone prolong the survival of patients receiving intravenous or oral melphalan for multiple myeloma: Cancer and Leukemia Group B experienceG G Cornwell, T F Pajak, S Kochwa, et al.
Cancer Clinical Trials|January 1, 1981
MER immunotherapy and combination chemotherapy for advanced, recurrent Hodgkin's disease. Cancer and Leukemia Group B studyV Vinciguerra, M Coleman, T F Pajak, et al.
The Review of Scientific Instruments|January 3, 2020
Multicolor femtosecond pump-probe system with single-electron sensitivity at low temperatures and high magnetic fieldsC Traum, P Henzler, S Lohner, et al.
Pageof 10